Training to improve anal cancer screening and care in Nigeria
This trial focuses on implementing anal cancer screening and treatment in Nigeria by working with trained medical professionals. If you meet the professional and community-experience requirements, it may help improve access to screening and care for people at higher risk, including sexual and gender minority communities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a medical degree (like MBBS or an equivalent)
- You have worked with the clinical HIV/AIDS community for at least 2 to 5 years
- You are registered with Nigeria’s Medical and Dental Council
- You have a current medical practicing license
- You are willing to work with the sexual and gender minority community
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way for doctors in community clinics to estimate prostate cancer risk in men aged 40 to 79. It aims to improve early detection and care in Nigeria.
This study offers home-based education and cervical cancer screening using a simple vaginal self-collection method. It aims to increase access to care for women living with HIV in Nigeria.
This study looks at how to improve cervical cancer screening and treatment for women living with HIV in Kenya. It involves group discussions to gather your views and experiences, which will help shape better care.
This study tests better ways to find and treat HIV in young people (ages 15-24) in Nigeria. It offers either HIV prevention medicine (PrEP) if you are HIV-negative, or HIV treatment if you are newly diagnosed with HIV.
This trial is for third-year medical students. It teaches them how to encourage Latinx transmasculine individuals to get screened for cervical cancer, which can help save lives.
This trial tests a prevention program for anal cancer in men who have sex with men who are at higher risk, such as those with HIV or taking PrEP. It aims to find and treat early signs of anal cancer to stop it from developing.
Hear when a new Education, Medical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.